US 6395712
Sensitization of HER-2/neu overexpressing cancer cells to chemotherapy
expired A61KA61K38/162A61K48/00
Quick answer
US patent 6395712 (Sensitization of HER-2/neu overexpressing cancer cells to chemotherapy) held by The Board of Regents of the University of Texas System expires Mon May 23 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue May 28 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 23 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 42
- CPC classes
- A61K, A61K38/162, A61K48/00, A61K9/1272, A61P